Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.50, read 2026-11-02
Ethical does not pass the values gate
Price277.95 USD
Fair value250.03
Ethical score70.0/100
Value readOvervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-11-05Read Markup292.02-4.8% to today Accumulation gives way to Markup after a 7% rise in 4 weeks
2026-10-11Read Accumulation272.40+2.0% to today ✓Distribution gives way to Accumulation
2026-10-02Read Distribution272.40+2.0% to today Markup gives way to Distribution after a 6% rise in 8 weeks
2026-08-04Read Markup255.88+8.6% to today ✓Distribution gives way to Markup after a 6% rise in 5 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Cheniere Energy Inc holds its Markup at $277.95. The statistical read favours the buyers, held for 14 days.
As held on the ledger · 2026-11-06
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 14 days
Price at the screen
$277.95
Valuation
22.15 trailing · 15.02 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.00
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
53.29%
Below 33%
Interest-bearing debt is 53.3% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
4.88%
Below 49%
Money owed to the company is 4.9% of assets, under the 49% limit.
Pass
Revenue purity
0.53%
Below 5%
Only 0.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Cheniere Energy's business is in a permissible area, but its interest-bearing debt is about 53% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LNG's ethical verdict changes
Today LNG does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 6 Nov 2026: it trades above our $250.03 fair value estimate, narrow competitive moat, 39.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. The price runs 11.2% above the base estimate.
Third-party analyst targets: 21 covering, consensus Buy. The average target sits +17% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $250.03, with a range of $235.80 to $287.53, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
LNG ships move but price sits high
When a tanker loads at Sabine Pass or Corpus Christi the gas heads to buyers who pay in euros or yen. Cheniere captures that flow yet the shares sit 11 percent above our fair value with zero margin of safety, so we pass.
Revenue climbs 24 percent and return on equity reaches 29 percent, yet profit margins stay thin at 7 percent and the moat is only narrow. In a cyclical midstream business a 13.5 times forward multiple often signals peak earnings rather than value, especially when the cycle can turn on one cold winter or one warm one.
Gas price swings, permit delays and shifting export rules remain real threats even if the ethical screen is cleared. Analyst targets sit higher still, but those forecasts rarely price the troughs that follow the peaks. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
LNG trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markup · changed$292.02-2.2%Entry 17
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303.
2026-10-29Accumulation$298.67+4.2%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Accumulation$286.60+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Accumulation$286.60+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Accumulation$286.60+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$286.60+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$286.60+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$286.60+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$286.60-0.1%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Accumulation$286.92+5.3%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (22 analysts) rates it strong buy, with a mean price target of $303.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
